TABLE 3.
Relationship of baseline medical history with death. P values were calculated from log rank test for equality of survival
| N | Alive | N | Died | P (log rank test) | |
|---|---|---|---|---|---|
| Chronic transfusion program, no. {%) | 479 | 64 (13.4%) | 10 | 6 (60.0%) | <.001a |
| History of stroke, no. (%) | 482 | 47 (9.8%) | 10 | 5 (50.0%) | .001a |
| Age ≥ 13 years, no. (%) | 487 | 227 (46.6%) | 10 | 9 (90.0%) | .008a |
| History of asthma, no (%) | 483 | 113 (23.4%) | 10 | 6 (60.0%) | .009a |
| 3+ Severe pain episodes past year, no. (%) | 487 | 91 (18.6%) | 10 | 5 (50.0%) | .013a |
| oc-thalassemia gene deletion, no. (%) | 459 | 147 (32.0%) | 9 | 5 (55.6%) | .09 |
| History of ACS or pneumonia, no (%) | 482 | 232 (48.1%) | 10 | 7 (70.0%) | .17 |
| Hemoglobin SS genotype, no (%) | 487 | 364 (74.7%) | 10 | 8 (80.0%) | .70 |
| Male gender, no (%) | 487 | 248 (50.9%) | 10 | 6 (60.0%) | .64 |
| Hydroxyurea treatment, no (%) | 483 | 177 (36.6%) | 10 | 4 (40.0%) | .88 |
a
Significant after adjusting for multiple hypothesis testing using False Discovery Rate < 0.05.